Skip to content
Tenfell
Closed tender
Published 23 Sep 2022

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.

NHS England · London

Key facts

Estimated value
£326,826,824
Closing date
24 Oct 2022
Contract starts
01 Mar 2023
Contract ends
28 Feb 2025
Procedure
Open procedure (above threshold)
Buyer type
Central government

Description

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.

Offer reference number: CM/PHR/20/5606

CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.